Literature DB >> 10323885

Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.

A Rashid1, M Zahurak, S N Goodman, S R Hamilton.   

Abstract

BACKGROUND: The genetic epidemiology of colorectal adenomas has not been studied prospectively in colonoscopy patients without cancer. AIMS: To study genetic alterations in colorectal adenomas and correlate these with patient demographics and adenoma characteristics.
METHODS: Mutations and allelic deletions in 201 adenomas from 60 patients were compared with demographic features, adenoma characteristics, and family history.
RESULTS: The most common alteration was K-ras proto-oncogene mutation, present in 35% of adenomas and 65% of patients. Patients 65 years of age and older had a decreased probability of K-ras mutations (26% versus 45%). Overexpression of p53 gene product was present in only 6% of adenomas but was more frequent in villous or tubulovillous adenomas (19% versus 3%). Allelic loss of chromosome 18q was present in only 2% of adenomas and was significantly less frequent than p53 overexpression. DNA replication errors (RER) were present in 7% of adenomas and 15% of patients, including multiple adenomas in four patients (two with hereditary non-polyposis colorectal cancer syndrome). Only 36% of RER positive adenomas had alteration of BAT-26 alleles, none had alteration of BAT-25, and only one (8%) had mutation in the transforming growth factor beta type II receptor gene. RER positive adenomas were more likely to have a K-ras mutation. In patients with multiple adenomas, there was concordance of p53 overexpression and RER but not of K-ras mutations.
CONCLUSIONS: Genetic progression in colorectal adenomas is heterogeneous, involving factors related to patient age and the presence of RER for the occurrence of ras mutations, but different intraindividual characteristics for the occurrence of p53 alterations and RER.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323885      PMCID: PMC1727525          DOI: 10.1136/gut.44.6.826

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  53 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

2.  Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.

Authors:  M Konishi; R Kikuchi-Yanoshita; K Tanaka; M Muraoka; A Onda; Y Okumura; N Kishi; T Iwama; T Mori; M Koike; K Ushio; M Chiba; S Nomizu; F Konishi; J Utsunomiya; M Miyaki
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

3.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Prognostic significance of K-ras mutations in colorectal carcinoma.

Authors:  J Benhattar; L Losi; P Chaubert; J C Givel; J Costa
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

7.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

8.  Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Authors:  R Kikuchi-Yanoshita; M Konishi; H Fukunari; K Tanaka; M Miyaki
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

9.  p53 expression in colorectal adenomas.

Authors:  L Kaklamanis; K C Gatter; N Mortensen; R J Baigrie; A Heryet; D P Lane; A L Harris
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

10.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

View more
  22 in total

1.  Missense mutations in MLH1, MSH2, KRAS, and APC genes in colorectal cancer patients in Malaysia.

Authors:  Nor Azian Abdul Murad; Zulhabri Othman; Melati Khalid; Zuraini Abdul Razak; Rosniza Hussain; Sukumar Nadesan; Ismail Sagap; Isa Mohamed Rose; Wan Zurinah Wan Ngah; Rahman Jamal
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

2.  Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway.

Authors:  N J Hawkins; P Gorman; I P Tomlinson; P Bullpitt; R L Ward
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance.

Authors:  Jun Wan; Zi-Qi Zhang; Wei-Di You; Hua-Kui Sun; Jian-Ping Zhang; Ya-Hong Wang; Yong-He Fu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

4.  The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.

Authors:  Hiu-Yee Kwan; Zhijun Yang; Wang-Fun Fong; Yong-Mei Hu; Zhi-Ling Yu; Wen-Luan Wendy Hsiao
Journal:  J Gastroenterol       Date:  2012-06-23       Impact factor: 7.527

5.  Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations.

Authors:  Enkh-Amar Yadamsuren; Szilvia Nagy; Laszlo Pajor; Agnes Lacza; Barna Bogner
Journal:  Pathol Oncol Res       Date:  2012-06-23       Impact factor: 3.201

6.  Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Authors:  Robert P Whitehead; Sheryl McCoy; John S Macdonald; Saul E Rivkin; Marcus A Neubauer; Shaker R Dakhil; Heinz-Josef Lenz; Michael S Tanaka; James L Abbruzzese
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

7.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 8.  Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers.

Authors:  David J Harriss; N Tim Cable; Keith George; Thomas Reilly; Andrew G Renehan; Najib Haboubi
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

9.  Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.

Authors:  Adam Naguib; Panagiota N Mitrou; Laura J Gay; James C Cooke; Robert N Luben; Richard Y Ball; Alison McTaggart; Mark J Arends; Sheila A Rodwell
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

10.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.